Pregled bibliografske jedinice broj: 297584
Fatal hyponatremia and other metabolic disturbances associated with psychotropic drug polypharmacy
Fatal hyponatremia and other metabolic disturbances associated with psychotropic drug polypharmacy // International journal of clinical pharmacology and therapeutics, 45 (2007), 5; 289-292 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 297584 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Fatal hyponatremia and other metabolic disturbances associated with psychotropic drug polypharmacy
Autori
Vučičević, Željko ; Degoricija, Vesna ; Alfirević, Zrinka ; Vukičević-Badouin Dina
Izvornik
International journal of clinical pharmacology and therapeutics (0946-1965) 45
(2007), 5;
289-292
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
hyponatremia; SIADH; antipsychotics
Sažetak
Objective was to report a case of fatal hyponatremia, marked hyperglycemia, and acute pancreatitis following simultaneous administration of paroxetine, fluphenazine, haloperidol and olanzapine. A 44-year-old non- diabetic male was admitted unconsciously, with severe hyponatremia, hyperglycemia and bradypnea. The patient had a history of long-term treatment with paroxetine, fluphenazine, haloperidol and olanzapine. Upon arrival, the plasma sodium level was 104 mmol/L, and blood glucose was 940 mg/dL. The therapy consisted of ventilatory support and intensive correction of hyponatremia and hyperglycemia. 2 hours later, hypotension and refractory cardiac arrest occured. The autopsy disclosed severe cerebral edema as cause of death, and a modest hemorrhagic pancreatitis. Paroxetine is a selective serotonin reuptake inhibitor which stimulates antidiuretic hormone (ADH) release and may cause the syndrome of inappropriate ADH secretion with consecutive hyponatremia. Fluphenazine and haloperidol may contribute to this syndrome. Fluphenazine, and particulary olanzapine are assiciated with an increased incidence of diabetes. Olanzapine has been reported as a risk factor for acute pancreatitis. The Naranjo probability scale was not applicable because of almost immediate lethal outcome. Polypharmacy increases the risk of various adverse reactions. Adverse effects of paroxetine and many antipsychotic drugs, such as hyponatremia and hyperglycemia, should be monitored periodically to prevent complications. The role of olanzapine in the etiology of acute pancreatitis remains to be evaluated.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
KBC "Sestre Milosrdnice"
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- BIOSIS Previews (Biological Abstracts)
- EMBASE (Excerpta Medica)
- MEDLINE